| Financial Year |
March 31 2023 |
| Monetary Funds |
472,014,898.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
999,601.20 |
| Accounts Receivable |
245,536,443.60 |
| Advances to Suppliers |
11,779,562.67 |
| Other Receivables |
3,610,846.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
189,891,242.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,879,250.33 |
| Total Current Assets |
960,921,647.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,518,941.36 |
| Investment Properties |
-- |
| Fixed Assetes |
386,881,525.39 |
| Under-construction Projects |
31,220,529.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,239,892.82 |
| R&D expenses |
-- |
| Goodwill |
5,389,670.76 |
| Long-Term Deferred and Prepaid Expenses |
15,839,092.02 |
| Deferred Income Tax Assets |
12,480,231.37 |
| Other Non-Current Assets |
6,479,227.68 |
| Sub-Total of Non-Current Assets |
583,316,836.04 |
| Total Assets |
1,544,238,483.89 |
| Short-Term Loans |
120,053,888.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,234,363.96 |
| Accounts Payable |
101,620,750.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,683,942.65 |
| Taxes Payable |
9,360,638.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,701,238.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,698,617.61 |
| Other Current Liabilities |
1,345,019.21 |
| Sub-Total of Current Liabilities |
355,326,803.45 |
| Long-term Loans |
44,000,000.00 |
| Bonds Payable |
287,725,606.55 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,719,291.82 |
| Deferred Income Tax Liabilities |
11,380,210.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
371,700,723.12 |
| Total Liabilities |
727,027,526.57 |
| Paid-In Capital(Or Share Stock) |
156,990,775.00 |
| Capital Surplus |
242,307,269.01 |
| Surplus Reserve |
32,620,471.50 |
| LESS:Treasury Stock |
1,151,010.00 |
| Undistributed Profits |
327,681,531.83 |
| Minority Stockholder's Interest |
5,685,165.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
811,525,791.38 |
| Owner's Equity（Stockholder's Equity） |
817,210,957.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,544,238,483.89 |
